Skip to main content
. 2019 Mar 4;14(3):e0213304. doi: 10.1371/journal.pone.0213304

Table 1. Demographic and clinical characteristics of the study population.

Characteristics Total Unlikely TB Unconfirmed TB Confirmed TB Overall
(N = 222) (n = 96) (n = 93) (n = 33) p-value
Demographics and anthropometric parameters
Age (years), median (IQR) 5.8 (2.4, 10.7) 5.5 (2.7, 10.7) 4.9 (1.8, 10.3) 9.8 (2.3, 13.4) 0.20
Age (years) 0.36
    0–5 105 (47.3) 46 (47.9) 47 (50.5) 12 (36.4)
    6–10 48 (21.6) 22 (22.9) 20 (21.5) 6 (18.2)
    11–15 62 (27.9) 27 (28.1) 22 (23.7) 13 (39.4)
    16–17 7 (3.2) 1 (1.0) 4 (4.3) 2 (6.1)
Male gender 134 (60.4) 59 (61.5) 58 (62.4) 17 (51.5) 0.53
BCG vaccination scar 218 (99.1) 94 (98.9) 91 (98.9) 33 (100.0) 0.84
Height (cm) 113.0 (85.0, 140.0) 112.0 (90.0, 138.0) 110.0 (80.0, 138.0) 130.0 (90.0, 150.0) 0.16
Weight (kg) 18.0 (11.0, 31.0) 18.0 (12.0, 30.0) 17.5 (10.0, 29.5) 23.0 (11.0, 36.0) 0.52
BMI (raw) 15.6 (13.7, 18.1) 16.0 (13.8, 18.2) 16.0 (14.2, 18.2) 15.0 (13.0, 16.6) 0.15
BMI z-score for sex and age, median (IQR) -0.6 (-2.0, 0.8) -0.4 (-1.8, 1.0) -0.4 (-2.0, 0.6) -1.7 (-2.6, -0.4) 0.01
BMI z-score ≤-2 55 (25.5) 19 (20.2) 23 (25.8) 13 (39.4) 0.09
Personal medical history
History of TB 10 (4.5) 4 (4.2) 4 (4.3) 2 (6.1) 0.82
Clinical and chest radiography characteristics
At least one clinical sign or symptom consistent with TB 175 (78.8) 63 (65.6) 88 (94.6) 24 (72.7) <0.001
Fever 9 (4.1) 2 (2.1) 6 (6.5) 1 (3.0) 0.30
Failure to thrive 25 (20.3) 6 (10.9) 12 (25.0) 7 (35.0) 0.04
Cough 156 (70.3) 56 (58.3) 81 (87.1) 19 (57.6) <0.001
Dyspnea 34 (15.3) 9 (9.4) 19 (20.4) 6 (18.2) 0.09
Night sweat 8 (3.6) 4 (4.2) 2 (2.2) 2 (6.1) 0.44
Chest pain 25 (11.3) 7 (7.3) 15 (16.1) 3 (9.1) 0.15
Hemoptysis 7 (3.2) 4 (4.2) 3 (3.2) 0 (0.0) 0.68
Neck pain or stiffness 14 (6.3) 8 (8.3) 5 (5.4) 1 (3.0) 0.60
Headache 1 (0.5) 1 (1.0) 0 (0.0) 0 (0.0) 1.00
TB-CXR <0.001
    No 84 (37.8) 72 (75.0) 4 (4.3) 8 (24.2)
    Yes 111 (50.0) 6 (6.3) 87 (93.5) 18 (54.5)
    Not done 27 (12.2) 18 (18.8) 2 (2.2) 7 (21.2)
Length of stay (days), median (IQR) 9.0 (6.0, 13.0) 7.0 (4.0, 10.0) 9.0 (7.0, 13.0) 14.0 (7.0, 17.0) <0.001
Laboratory parameters
HIV result 0.01
    Negative 61 (27.5) 25 (26.0) 20 (21.5) 16 (48.5)
    Positive 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
    Unknown/Not done 161 (72.5) 71 (74.0) 73 (78.5) 17 (51.5)
QFT-Plus result <0.001
    Negative 176 (79.3) 87 (90.6) 74 (79.6) 15 (45.5)
    Positive 45 (20.3) 9 (9.4) 18 (19.4) 18 (54.5)
    Indeterminate 1 (0.4) 0 (0) 1 (1.0) 0 (0)
Sputum AFB Smear <0.001
    Negative 31 (14.0) 10 (10.4) 18 (19.4) 3 (9.1)
    Positive 6 (2.7) 0 (0.0) 1 (1.1) 5 (15.2)
    Unknown/Not done 185 (83.3) 86 (89.6) 74 (79.6) 25 (75.8)
Sputum culture <0.001
    Negative 143 (64.4) 66 (68.8) 67 (72.0) 10 (30.3)
    Positive 18 (8.1) 0 (0.0) 0 (0.0) 18 (54.5)
    Unknown/Not done 61 (27.5) 30 (31.3) 26 (28.0) 5 (15.2)
GenXpert <0.001
    Negative 162 (73.0) 71 (74.0) 72 (77.4) 19 (57.6)
    Positive 9 (4.1) 0 (0.0) 0 (0.0) 9 (27.3)
    Unknown/Not done 51 (23.0) 25 (26.0) 21 (22.6) 5 (15.2)
Biopsy done (both pulmonary and EPTB samples) 55 (24.8) 26 (27.1) 11 (11.8) 18 (54.5) <0.001
Biopsy results (both pulmonary and EPTB samples) <0.001
    Negative 40 (18.0) 26 (27.1) 11 (11.8) 3 (9.1)
    Positive 15 (6.8) 0 (0.0) 0 (0.0) 15 (45.5)
    Not done 167 (75.2) 70 (72.9) 82 (88.2) 15 (45.5)

Values are in frequency and % unless otherwise indicated; IQR, interquartile range; TB, tuberculosis; TB-CXR, chest radiograph abnormalities consistent to TB; BCG, Bacille Calmette-Guérin; BMI, body mass index; AFB, Acid-Fast Bacilli; EPTB, extra-pulmonary TB.